Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Min Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3675-9695; OpenAlex author ID A5100403002. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 4 papers · 2024: none · 2025: none · 2026: 2 papers

Papers 7

  1. Current Status and Influencing Factors of Postoperative Sarcopenia in Pancreatic Cancer Patients. Co-author DOI 10.1245/s10434-025-18415-1↗
  2. ASO Visual Abstract: Current Status and Influencing Factors of Postoperative Sarcopenia in Pancreatic Cancer Patients. Co-author DOI 10.1245/s10434-025-19074-y↗
  3. Radical Resection Combined With Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy: A Report of 36 Consecutive Cas… Co-author DOI 10.1097/sla.0000000000005797↗
  4. Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone… Co-author DOI 10.1186/s12885-023-10529-7↗
  5. Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial. Co-author DOI 10.1245/s10434-023-13383-w↗
  6. Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc. Co-author DOI 10.3892/ijo.2022.5456↗
  7. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Co-author DOI 10.1016/s1499-3872(15)60400-3↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiuju Tian · 2 shared papers, 2026 · strength 0.63
  2. Leying Chen · 2 shared papers, 2026 · strength 0.63
  3. Tingbo Liang · 3 shared papers, 2023 · strength 0.44
  4. Luyi Zhang · 1 shared paper, 2026 · strength 0.32
  5. Luyi Zhang · 1 shared paper, 2026 · strength 0.32
  6. Qi Zhang · 2 shared papers, 2023 · strength 0.30
  7. Xiang Li · 2 shared papers, 2023 · strength 0.29
  8. Risheng Que · 2 shared papers, 2023 · strength 0.29
  9. Yunjian Wang · 1 shared paper, 2023 · strength 0.18
  10. Bo Meng · 1 shared paper, 2023 · strength 0.18
  11. Luyang Zhang · 1 shared paper, 2023 · strength 0.18
  12. Qiong Li · 1 shared paper, 2023 · strength 0.18
  13. Enze Wang · 1 shared paper, 2023 · strength 0.18
  14. Qihan Fu · 1 shared paper, 2023 · strength 0.15
  15. Tingbo Liang · 1 shared paper, 2023 · strength 0.15
  16. Xueli Bai · 1 shared paper, 2023 · strength 0.15
  17. Jianzhen Shan · 1 shared paper, 2023 · strength 0.15
  18. Tao Ma · 1 shared paper, 2023 · strength 0.15
  19. FangYan Lu · 1 shared paper, 2023 · strength 0.15
  20. Tianan Jiang · 1 shared paper, 2023 · strength 0.15
  21. Yuntao Zhang · 1 shared paper, 2023 · strength 0.15
  22. Meng Wang · 1 shared paper, 2023 · strength 0.14
  23. Jun Yu · 1 shared paper, 2023 · strength 0.14
  24. Xueli Bai · 1 shared paper, 2023 · strength 0.14
  25. Sheng Yan · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.